Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
jRCT1011210077Recruiting
Open-label trial of remimazolam, sponsored by Mitsutaka Edanaga. Primary endpoint: dPmx. Started Mar 2022; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on jRCT1011210077.